Alerus Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4K | Buy |
+210
| New | +$17.4K | ﹤0.01% | 317 |
|
|
2024
Q4 | – | Sell |
-34,314
| Closed | -$3.39M | – | 168 |
|
|
2024
Q3 | $3.39M | Sell |
34,314
-346
| -1% | -$34.2K | 0.25% | 81 |
|
|
2024
Q2 | $3.21M | Sell |
34,660
-137
| -0.4% | -$12.7K | 0.24% | 77 |
|
|
2024
Q1 | $3.3M | Sell |
34,797
-56
| -0.2% | -$5.31K | 0.25% | 83 |
|
|
2023
Q4 | $3.11M | Sell |
34,853
-19,802
| -36% | -$1.77M | 0.25% | 82 |
|
|
2023
Q3 | $3.99M | Buy |
54,655
+349
| +0.6% | +$25.5K | 0.35% | 71 |
|
|
2023
Q2 | $4.52M | Buy |
54,306
+954
| +2% | +$79.4K | 0.38% | 74 |
|
|
2023
Q1 | $4.07M | Sell |
53,352
-19,419
| -27% | -$1.48M | 0.36% | 77 |
|
|
2022
Q4 | $6.04M | Buy |
72,771
+2,600
| +4% | +$216K | 0.55% | 53 |
|
|
2022
Q3 | $5.57M | Buy |
70,171
+31,937
| +84% | +$2.53M | 0.55% | 46 |
|
|
2022
Q2 | $2.84M | Buy |
+38,234
| New | +$2.84M | 0.26% | 87 |
|
|
2022
Q1 | – | Sell |
-2,378
| Closed | -$266K | – | 191 |
|
|
2021
Q4 | $266K | Sell |
2,378
-27,009
| -92% | -$3.02M | 0.02% | 169 |
|
|
2021
Q3 | $3.69M | Buy |
29,387
+1,571
| +6% | +$197K | 0.34% | 77 |
|
|
2021
Q2 | $3.77M | Buy |
27,816
+272
| +1% | +$36.8K | 0.38% | 68 |
|
|
2021
Q1 | $3.74M | Buy |
27,544
+6,487
| +31% | +$880K | 0.39% | 71 |
|
|
2020
Q4 | $2.97M | Buy |
21,057
+833
| +4% | +$117K | 0.3% | 86 |
|
|
2020
Q3 | $2.25M | Buy |
20,224
+9,520
| +89% | +$1.06M | 0.25% | 95 |
|
|
2020
Q2 | $1.2M | Buy |
10,704
+729
| +7% | +$81.6K | 0.14% | 109 |
|
|
2020
Q1 | $772K | Buy |
9,975
+91
| +0.9% | +$7.04K | 0.11% | 111 |
|
|
2019
Q4 | $940K | Buy |
9,884
+120
| +1% | +$11.4K | 0.11% | 108 |
|
|
2019
Q3 | $745K | Buy |
+9,764
| New | +$745K | 0.1% | 110 |
|
|
2019
Q1 | – | Sell |
-18,138
| Closed | -$1.3M | – | 154 |
|
|
2018
Q4 | $1.3M | Buy |
+18,138
| New | +$1.3M | 0.2% | 94 |
|